(Q31811573)

English

Concomitant cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy plus highly active antiretroviral therapy in patients with human immunodeficiency virus-related, non-Hodgkin lymphoma

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

4 July 2017

Concomitant cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy plus highly active antiretroviral therapy in patients with human immunodeficiency virus-related, non-Hodgkin lymphoma (English)

1 reference

Europe PubMed Central

4 July 2017

0 references

anti-retroviral agent

0 references

1 reference

based on heuristic

inferred from title

non-Hodgkin lymphoma

1 reference

based on heuristic

inferred from title

1 reference

ORCID Public Data File 2021

author name string

Vaccher E

1

1 reference

Europe PubMed Central

4 July 2017

Spina M

2

1 reference

Europe PubMed Central

4 July 2017

di Gennaro G

3

1 reference

Europe PubMed Central

4 July 2017

Talamini R

4

1 reference

Europe PubMed Central

4 July 2017

Nasti G

5

1 reference

Europe PubMed Central

4 July 2017

Schioppa O

6

1 reference

Europe PubMed Central

4 July 2017

Vultaggio G

7

1 reference

Europe PubMed Central

4 July 2017

Tirelli U

8

1 reference

Europe PubMed Central

4 July 2017

language of work or name

0 references

publication date

1 January 2001

1 reference

Europe PubMed Central

4 July 2017

number of pages

9

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

4 July 2017

91

1 reference

Europe PubMed Central

4 July 2017

1

1 reference

Europe PubMed Central

4 July 2017

155-163

1 reference

Europe PubMed Central

4 July 2017

Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study. Swiss HIV Cohort Study

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010101%2991%3A1%3C155%3A%3AAID-CNCR20%3E3.0.CO%3B2-B

21 January 2018

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010101%2991%3A1%3C155%3A%3AAID-CNCR20%3E3.0.CO%3B2-B

21 January 2018

Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group.

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010101%2991%3A1%3C155%3A%3AAID-CNCR20%3E3.0.CO%3B2-B

21 January 2018

Non-Hodgkin's lymphoma among people with AIDS: incidence, presentation and public health burden. AIDS/Cancer Study Group.

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010101%2991%3A1%3C155%3A%3AAID-CNCR20%3E3.0.CO%3B2-B

21 January 2018

Human immunodeficiency virus-related lymphoma treatment with intensive combination chemotherapy. French-Italian Cooperative Group

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010101%2991%3A1%3C155%3A%3AAID-CNCR20%3E3.0.CO%3B2-B

21 January 2018

Pilot trial of infusional cyclophosphamide, doxorubicin, and etoposide plus didanosine and filgrastim in patients with human immunodeficiency virus-associated non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010101%2991%3A1%3C155%3A%3AAID-CNCR20%3E3.0.CO%3B2-B

21 January 2018

Low-dose compared with standard-dose m-BACOD chemotherapy for non-Hodgkin's lymphoma associated with human immunodeficiency virus infection. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010101%2991%3A1%3C155%3A%3AAID-CNCR20%3E3.0.CO%3B2-B

21 January 2018

HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010101%2991%3A1%3C155%3A%3AAID-CNCR20%3E3.0.CO%3B2-B

21 January 2018

Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010101%2991%3A1%3C155%3A%3AAID-CNCR20%3E3.0.CO%3B2-B

21 January 2018

Maintenance antiretroviral therapies in HIV-infected subjects with undetectable plasma HIV RNA after triple-drug therapy. AIDS Clinical Trials Group Study 343 Team

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010101%2991%3A1%3C155%3A%3AAID-CNCR20%3E3.0.CO%3B2-B

21 January 2018

Diagnosis of hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010101%2991%3A1%3C155%3A%3AAID-CNCR20%3E3.0.CO%3B2-B

21 January 2018

Reporting results of cancer treatment

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010101%2991%3A1%3C155%3A%3AAID-CNCR20%3E3.0.CO%3B2-B

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010101%2991%3A1%3C155%3A%3AAID-CNCR20%3E3.0.CO%3B2-B

21 January 2018

The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010101%2991%3A1%3C155%3A%3AAID-CNCR20%3E3.0.CO%3B2-B

21 January 2018

HIV-protease inhibitors

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010101%2991%3A1%3C155%3A%3AAID-CNCR20%3E3.0.CO%3B2-B

21 January 2018

Opportunistic infection and immunologic function in patients with human immunodeficiency virus-associated non-Hodgkin's lymphoma treated with chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010101%2991%3A1%3C155%3A%3AAID-CNCR20%3E3.0.CO%3B2-B

21 January 2018

Reconstitution of long-term T helper cell function after zidovudine therapy in human immunodeficiency virus-infected patients

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010101%2991%3A1%3C155%3A%3AAID-CNCR20%3E3.0.CO%3B2-B

21 January 2018

Rate of HIV-1 RNA rebound upon stopping antiretroviral therapy.

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010101%2991%3A1%3C155%3A%3AAID-CNCR20%3E3.0.CO%3B2-B

21 January 2018

Identifiers

10.1002/1097-0142(20010101)91:1<155::AID-CNCR20>3.0.CO;2-B

1 reference

Europe PubMed Central

4 July 2017

1 reference

Europe PubMed Central

4 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q31811573&oldid=1766269967"